GlassScriptPhysician profile
Jay A Motola
NPI 1174509814
$21,523.26
in general payments reported to CMS, 2019-2025
35 companies · $1,828 in 2025
The $1,828 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,578 · 2020: $3,330 · 2021: $1,043 · 2022: $1,993 · 2023: $3,350 · 2024: $1,401 · 2025: $1,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,893 · Food and Beverage: $1,322 · Travel and Lodging: $964 · Honoraria: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,893.00 |
| Food and Beverage | $1,322.28 |
| Travel and Lodging | $964.11 |
| Honoraria | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,808.00 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Varian Medical Systems, INC. | $3,990.89 | 2019-2020 | |
| Medtronic, INC. | $1,965.83 | 2021-2025 | Altaviva, Interstim, Lapro-Clip |
| Teleflex LLC | $1,211.60 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $882.00 | 2021-2023 | |
| Endocare, INC. | $824.78 | 2019 | |
| Astellas Pharma US INC | $582.95 | 2019-2025 | Veozah |
| Ambu A/S | $550.00 | 2024 | |
| Coloplast Corp | $539.71 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $523.50 | 2023-2024 | Aveed, Xiaflex, Edex |
| Bard Peripheral Vascular, INC. | $400.00 | 2023 | |
| Ethicon INC. | $333.00 | 2020 | |
| Sentynl Therapeutics, INC. | $293.00 | 2025 | |
| Pfizer INC. | $245.63 | 2019-2020 | |
| Bard Access Systems, INC. | $235.00 | 2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $229.96 | 2019-2022 | |
| Richard Wolf Medical Instruments Corp. | $145.85 | 2019 | |
| Healthtronics Stone Solutions, LLC | $144.60 | 2019 | |
| Alnylam Pharmaceuticals INC. | $89.50 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $84.86 | 2019-2021 | |
| Blue Earth Diagnostics | $66.13 | 2019-2022 | |
| Urogen Pharma, INC. | $58.45 | 2022-2023 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $36.27 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $34.37 | 2022 | |
| Dendreon Pharmaceuticals LLC | $30.26 | 2019 | |
| Myovant Sciences INC. | $29.33 | 2022 | |
| Clarus Therapeutics INC. | $27.96 | 2021 | |
| Amgen INC. | $24.27 | 2019 | |
| Medtronic USA, INC. | $22.87 | 2019 | |
| Allergan, INC. | $22.33 | 2019 | |
| Travere Therapeutics, INC. | $22.27 | 2019 | |
| Karl Storz Endoscopy-America | $22.00 | 2019 | |
| Olympus America INC. | $17.50 | 2021 | |
| Dentsply Ih INC. | $14.46 | 2021 | |
| Merck Sharp & Dohme LLC | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Motola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.